Infection Clinical Trial
Official title:
Revitalization of Teeth With Necrotic Pulps and Open Apexes Using Platelet-Rich Plasma
When root canals of infected teeth with closed ends are cleaned, disinfected and filled, the results are predictable with excellent outcomes. However, in a tooth with incomplete root development, the end of the root(s) must be closed before filling the root canals. One or two-step artificial barrier using mineral trioxide aggregate (MTA) has been used before filling the root canals of these teeth. Despite the high success of this treatment, this procedure does not result in complete root formation and these teeth are susceptible to root fracture. A number of case reports in scientific journal have shown the possibility for regeneration of nerve within the root canal space and continued root development in teeth with dead nerves and open ends. There is very little information regarding the use of stem cells and growth factors from the blood of patients to regenerate the nerves in these teeth. Platelet rich plasma (PRP) from whole blood has been mentioned in the literature as a potential ideal material for regeneration of nerves in these teeth. The purpose of this study is to investigate the use of PRP to regenerate tooth nerve and close the root ends in teeth with root canal infection and open root ends.
Procedures Participants in this study must be in overall good health and not allergic to the
materials used during this study treatment. If you agree to participate in this study, you
will receive a screening visit to determine whether you will qualify for the study. At that
time, your medical history will be reviewed, your blood pressure and pulse will be taken and
you will be asked to fill out detailed medical and dental histories. In addition, you will
receive an examination of your teeth and gums.
In the first appointment, after anesthetizing you with a local anesthetic similar to
Novocain and application of a rubber dam to isolate your tooth, an opening will be made into
the root canal(s). The canal(s) will be cleaned and medicated with antibiotics to get rid of
the infection and sealed with a temporary filling material. Except for the use of
antibiotics the rest of the procedures done in this appointment are similar to what the
investigators do for the patients for need root canal treatment.
In the second appointment, after providing anesthesia with Novocain and application of
rubber dam again, the temporary filling will be removed and the antibiotic will be removed
using sterile water. The canal will be then dried. During this appointment, 20 ml of whole
blood will be taken from your arm vein and will be used to prepare concentrated cells for
injection into the prepared canal and sealed again with a temporary filling material. This
part is different than what the investigators normally do for patients who need root canal
treatment. For those patients the investigators fill the canals and seal the opening into
the root canals with a permanent filling material.
You will return three to seven days later to the endodontic clinic and at that time, after
rubber dam application, the temporary filling material will be removed and the tooth will be
double sealed with permanent filling materials. This is an extra step that the investigators
normally do not take for patients who need root canal treatment. A dental assistant or a
dentist will call you to make an appointment at 3, 6, 12, 18, and 24 months following
completion of your root canal treatment to check the vitality of the tooth using an ice
stick and closure of the root end. Checking the process of healing in your tooth is similar
to what the investigators routinely do for our patients who require root canal treatment.
Risks The study will require drawing blood from your arm. Veins and arteries vary in size
from one person to another and from one side of the body to the other. Obtaining a blood
sample from some people may be more difficult than from others. Other risks associated with
having blood drawn are slight but may include bleeding, fainting or feeling light-headed,
hematoma (blood accumulating under the skin), and infection (a slight risk any time the skin
is broken). In rare instances, it may cause severe pain of infection. Depending upon the
complications, your dentist may decide to remove the PRP completely out of the root canal
and the use other procedures to treat your tooth. Should root canal failure occur, further
dental treatment will be rendered at no charge to you.
Benefits Whether or not you will benefit from this study is not yet known. However, there is
a possibility of saving the tooth with this procedure. Your participation will help dentists
learn about the importance of regeneration of nerves in teeth with infection and open root
ends, and may help save your tooth.
Participants' Rights Your participation in this study is voluntary. Your decision whether or
not to participate or terminate at any time will not affect your present or future treatment
here at the Dental School. You may withdraw from the study at any time that you want to.
Alternative Treatments You can choose not to participate in this study and have your tooth
treated with the standard root canal procedures or have it extracted. Refusal to participate
in this study will involve no penalties or loss of usual benefits to which you are entitled.
Confidentiality The medical information collected in this study will be available to the
investigators, the U.S. Food and Drug Administration, and the Institutional Review Board of
Loma Linda University. The results may be published but your name will not be used in
publications. However, submission of the information will be accomplished with strict
adherence to the professional standards of confidentiality. See attached PHI Authorization
for more information about your privacy. Your name and address will be kept on record at the
investigator's office in case you need to be contacted in the future about this study.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |